Case report of primary CD20 negative diffuse large B-cell lymphoma

Kanti Devi; Natashi Ali; Arsalan Ahmed

doi:10.1093/omcr/omab114

Case report of primary CD20 negative diffuse large B-cell lymphoma

Kanti Devi, Natashi Ali, Arsalan Ahmed

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Few groups of aggressive non-Hodgkin's lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well.

Original language	English (UK)
Article number	omab114
Pages (from-to)	447-449
Number of pages	3
Journal	Oxford Medical Case Reports
Volume	2021
Issue number	11
DOIs	https://doi.org/10.1093/omcr/omab114
Publication status	Published - 1 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/omcr/omab114

Cite this

@article{5d2fbe4731f74906bc6e7a22ec92c321,

title = "Case report of primary CD20 negative diffuse large B-cell lymphoma",

abstract = "Few groups of aggressive non-Hodgkin's lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well.",

author = "Kanti Devi and Natashi Ali and Arsalan Ahmed",

year = "2021",

month = nov,

day = "1",

doi = "10.1093/omcr/omab114",

language = "English (UK)",

volume = "2021",

pages = "447--449",

journal = "Oxford Medical Case Reports",

issn = "2053-8855",

publisher = "Oxford University Press",

number = "11",

}

TY - JOUR

T1 - Case report of primary CD20 negative diffuse large B-cell lymphoma

AU - Devi, Kanti

AU - Ali, Natashi

AU - Ahmed, Arsalan

PY - 2021/11/1

Y1 - 2021/11/1

N2 - Few groups of aggressive non-Hodgkin's lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well.

AB - Few groups of aggressive non-Hodgkin's lymphomas (NHL) that are refractory to standard chemotherapy are rarely reported. Primary CD20 negative diffuse large B cell lymphoma (DLBCL) without human immunodeficiency virus infection is an uncommon presentation and this case report is challenging in terms of diagnosis and treatment as well.

UR - https://www.scopus.com/pages/publications/85121225094

U2 - 10.1093/omcr/omab114

DO - 10.1093/omcr/omab114

M3 - Article

AN - SCOPUS:85121225094

SN - 2053-8855

VL - 2021

SP - 447

EP - 449

JO - Oxford Medical Case Reports

JF - Oxford Medical Case Reports

IS - 11

M1 - omab114

ER -

Case report of primary CD20 negative diffuse large B-cell lymphoma

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this